Growth Factor Delivery Systems for the Treatment of Cardiovascular Diseases - Biointerfaces: Where Material Meets Biology - page 101

123. X. Hao, A. Månsson Broberg, T. Gustafsson, K. H. Grinnemo,
P. Blomberg, A. J. Siddiqui, E. W ¨ rdell and C. Sylv ´ n, Biochem. Biophys.
Res. Commun., 2004, 315, 1058.
124. A. S. Salimath, E. A. Phelps, A. V. Boopathy, P.-l. Che, M. Brown,
A. J. Garc ´ a and M. E. Davis, PLoS One, 2012, 7, e50980.
125. A. Cittadini, M. Monti, V. Petrillo, G. Esposito, G. Imparato, A. Luciani,
F. Urciuolo, E. Bobbio, C. Natale, L. Sacc and P. Netti, Eur. J. Heart
Failure, 2011, 13, 1264.
126. Q. Sun, E. A. Silva, A. Wang, J. C. Fritton, D. J. Mooney, M. B. Schaer,
P. M. Grossman and S. Rajagopalan, Pharm. Res., 2010, 27, 264.
127. S. T. M. Nillesen, P. J. Geutjes, R. Wismans, J. Schalkwijk,
W. F. Daamen and T. H. van Kuppevelt, Biomaterials, 2007, 28, 1123.
128. J. H. Kim, Y. Jung, S.-H. Kim, K. Sun, J. Choi, H. Kim and Y. Park,
Biomaterials, 2011, 32, 6080.
129. F. Formiga, B. Pelacho, E. Garbayo, I. Imbuluzqueta, P. D´az-Herr´ez,
G. Abizanda, J. Gavira, T. Sim´n-Yarza, E. Albiasu, E. Tamayo,
F. Pr´sper and M. Blanco-Prieto, J. Control. Release, 2014, 10, 132.
130. J. V. Terrovitis, R. R. Smith and E. Marb´n, Circ. Res., 2010, 106, 479.
131. S. Fukuhara, S. Tomita, T. Nakatani, T. Fujisato, Y. Ohtsu, M. Ishida,
C. Yutani and S. Kitamura, Circ. J., 2005, 69, 850.
132. K. Kang, L. Sun, Y. Xiao, S.-H. Li, J. Wu, J. Guo, S. L. Jiang, L. Yang,
T. M. Yau, R. D. Weisel, M. Radisic and R.-K. Li, J. Am. Coll. Cardiol.,
2012, 60, 2237.
133. C. Penna, M.-G. Perrelli, J.-P. Karam, C. Angotti, C. Muscari,
C. N. Montero Menei and P. Pagliaro, J. Cell. Mol. Med., 2013, 17, 192.
134. P. D ´ az Herr ´ ez, E. Garbayo, T. Sim ´ n Yarza, F. R. Formiga, F. Prosper
and M. J. Blanco Prieto, Eur. J. Pharm. Biopharm., 2013, 85, 143.
135. H. Matsubara and N. Takehara, Hybrid Biotherapy Involving Autologous
Human Cardiac Stem Cell Transplantation Combined With the Controlled
Release of bFGF Using a Gelatin Hydrogel Sheet to Treat Severe Refractory
Heart Failure With Chronic Ischemic Cardiomyopathy, 2013.

d n 3 r 4 n g | 4

.